FDA Inspection
Apitoria Pharma Private LimitedApitoria Pharma Private Limited – FDA Inspection, Sep 15, 2026
Record Details
This FDA Inspection record concerns Apitoria Pharma Private Limited, with an inspection on September 15, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 40d6c3f5-b364-47e2-9eda-3d74a70526b7
Inspection Facts
- Inspection number
- 1336254
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Apitoria Pharma Private Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 27, 2024 | Not classified | Office of Inspections and Investigations | |
| October 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 11, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 19, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Apitoria Pharma Private Limited
- FDA Inspection 1254546 - 2024-09-27
- FDA Inspection 1116242 - 2019-10-25
- FDA Inspection 1060097 - 2018-06-11
- FDA Inspection 979741 - 2016-07-01
- FDA Inspection 892453 - 2014-04-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.